Presentation by Brian Gau, Pfizer: Oligonucleotide Mapping via LC-UV-MS/MS to Enable Comprehensive Primary Structure Characterization of mRNA Drug Substance
Presentation by Sarah Rogstad, FDA: The Use of Mass Spectrometry in Therapeutic Protein Biologics License Applications: A Retrospective Review Revisited
Presentation by Vamsi Kandhi, Pfizer: A Comprehensive Approach: MAM for Product and Process Understanding
Presentation by Brian Gfeller, Pfizer: Application of HT-MS to Support Process Analytical Characterization
Presentation by Sara Carillo, NIBRT: Characterizing AAV Quality Attributes Using Mass Spectrometry
Presentation by Bingchuan Wei, Genentech: Unveiling Structural-Function Relationship through Hydrogen Deuterium Exchange Coupled with Mass Spectrometry (HDX-MS)
Presentation by Rachel Shi, Genentech: Innovating Mass Spectrometry Approaches for Characterizing Emerging Modality Therapeutics
Presentation by Ben Niu, BMS: High-Throughput and Automation in Novel Modalities (bsAbs, ADCs) Characterizations and Beyond
Presentation by Serena Wu, Regeneron: Development of LCMS MAM for Protein and Oligonucleotide Therapies
Presentation by Aaron Bailey, AbCellera: Leveraging the Versatility of Size Exclusion Coupled to Mass Spectrometry (SEC-MS) to Accelerate Antibody Drug…